Historical record - last NADAC publication: 3/23/2022
Product Information
MUCINEX SINUS-MAX PRESSURE-CGH is a brand product labeled by RB Health (US) LLC, priced at $0.7369 per EA under NDC 63824069316. Its NADAC has been published 200 times since Sep 5, 2018.
The High Outlier badge above means this manufacturer's average price in the ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
MUCINEX SINUS-MAX PRESSURE-CGH
ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDEStrength
325; 10; 200; 5 mg/1; mg/1; mg/1; mg/1
Manufacturer
RB Health (US) LLCNDC
63824069316
Classification
Brand
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Last Updated
3/23/2022
Active Ingredients
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/1/2017
Pharmacological Classes
Price Statistics
The NADAC for MUCINEX SINUS-MAX PRESSURE-CGH has been published 200 times since Sep 5, 2018, and over the history we have for it it has risen 13.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7369 per EA |
|---|---|
| All-time high | $0.7673 (Oct 13, 2021) |
| All-time low | $0.6179 (Dec 19, 2018) |
| Median price | $0.7106 |
| Average price | $0.7036 |
| Largest weekly change | +12.6% (Mar 20, 2019) |
| Weeks tracked | 200 |
| Tracking since | Sep 5, 2018 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 81% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MUCINEX SINUS-MAX PRESSURE-CGH?
The current National Average Drug Acquisition Cost (NADAC) for MUCINEX SINUS-MAX PRESSURE-CGH, manufactured by RB Health (US) LLC, is $0.7369 per EA (NDC 63824069316), effective Jun 29, 2022.
How has the price of MUCINEX SINUS-MAX PRESSURE-CGH changed over time?
Over the history we have for it, the NADAC for MUCINEX SINUS-MAX PRESSURE-CGH has risen 13.8%. It has been tracked across 200 weekly CMS publications since Sep 5, 2018.
What are the highest and lowest recorded NADAC prices for MUCINEX SINUS-MAX PRESSURE-CGH?
Since Sep 5, 2018, the NADAC for MUCINEX SINUS-MAX PRESSURE-CGH has ranged from a low of $0.6179 (Dec 19, 2018) to a high of $0.7673 (Oct 13, 2021), with a median of $0.7106 per EA.
Are there cheaper alternatives to MUCINEX SINUS-MAX PRESSURE-CGH?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GNP COLD-FLU SEVERE CAPLET, is $0.1372 per EA — about 81% below MUCINEX SINUS-MAX PRESSURE-CGH.
Who manufactures MUCINEX SINUS-MAX PRESSURE-CGH?
MUCINEX SINUS-MAX PRESSURE-CGH (NDC 63824069316) is labeled by RB Health (US) LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification